Estimating the Contribution of the Prostate to Blood Dihydrotestosterone

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 11, 2003, Pages 5207-5211

  Toorians, Arno W F T ^a   Kelleher, Sharyn ^b   Gooren, Louis J ^a   Jimenez, Mark ^b   Handelsman, David J ^b,c  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF SYDNEY   (Australia)

^c ANZAC RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROSTANOLONE; TESTOSTERONE; TESTOSTERONE ESTER;

ADULT; AGE DISTRIBUTION; ARTICLE; AUSTRALIA; BLOOD SAMPLING; BODY BUILD; BODY HEIGHT; BODY MASS; BODY SURFACE; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; COVARIANCE; DOSE RESPONSE; DRUG BLOOD LEVEL; FEMALE; HEALTH CENTER; HORMONAL THERAPY; HORMONE BLOOD LEVEL; HORMONE DEFICIENCY; HUMAN; IMPLANTATION; INJECTION; MALE; NETHERLANDS; PRIORITY JOURNAL; PROSTATE; STANDARDIZATION; STATISTICAL SIGNIFICANCE; STEADY STATE; UNITED STATES;

ANDROGENS; DIHYDROTESTOSTERONE; FEMALE; HUMANS; MALE; PROSTATE; PROSTATECTOMY; TESTOSTERONE; TESTOSTERONE 5-ALPHA-REDUCTASE; TRANSSEXUALISM;

EID: 0344442660     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-030521     Document Type: Article

References (40)

1. Russell DW, Wilson JD 1994 Steroid 5α-reductase: two genes/two enzymes. Annu Rev Biochem 63:25-61
2. Steers WD 2001 5α-Reductase activity in the prostate. Urology 58:17-24
3. Pratis K, O'Donnell L, Ooi GT, McLachlan RI, Robertson DM 2000 Enzyme assay for 5α-reductase type 2 activity in the presence of 5α-reductase type 1 activity in rat testis. J Steroid Biochem Mol Biol 75:75-82
4. Quigley CA 1998 The androgen receptor: physiology and pathyphysiology. In: Nieschlag E, Behre HM, eds. Testosterone: action, deficiency, substitution, 2nd Ed. Berlin: Springer-Verlag; 33-106
5. Frick J, Aulitzky W 1991 Physiology of the prostate. Infection 19(Suppl 3): S115-S118
6. Gisleskog PO, Hermann D, Hammarlund-Udenaes M, Karlsson MO 1998 A model for the turnover of dihydrotestosterone in the presence of the irreversible 5α-reductase inhibitors GI198745 and finasteride. Clin Pharmacol Ther 64:636-647
7. Uygur MC, Arik AI, Altug U, Erol D 1998 Effects of the 5α-reductase inhibitor finasteride on serum levels of gonadal, adrenal, and hypophyseal hormones and its clinical significance: a prospective clinical study. Steroids 63:208-213
8. Miller LR, Partin AW, Chan DW, Bruzek DJ, Dobs AS, Epstein JI, Walsh PC 1998 Influence of radical prostatectomy on serum hormone levels. J Urol 160:449-453
9. Ghanadian R, Puah CM, Williams G, Shah PJ, McWhinney N 1981 Suppressive effects of surgical stress on circulating androgens during and after prostatectomy. Br J Urol 53:147-149
10. Lukkarinen O 1980 Total and SHBG-bound testosterone and 5α-dihydrotestosterone serum concentrations in normal elderly men and patients with benign prostatic hypertrophy before and after removal of the adenoma. Br J Urol 52:377-380
11. Lukkarinen O, Hammond GL, Kontturi M, Vihko R 1980 Peripheral and prostatic vein steroid concentrations in benign prostatic hypertrophy patients before and after removal of the adenoma. Scand J Urol Nephrol 14:225-227
12. Giltay EJ, Gooren LJ 2000 Effects of sex steroid deprivation/ administration on hair growth and skin sebum production in transsexual males and females. J Clin Endocrinol Metab 85:2913-2921
13. Handelsman DJ 1998 Clinical pharmacology of testosterone pellet implants. In: Nieschlag E, Behre HM, eds. Testosterone: action deficiency substitution, 2nd Ed. Berlin: Springer; 349-364
14. Snyder PJ, Lawrence DA 1980 Treatment of male hypogonadism with testosterone enanthate. J Clin Endocrinol Metab 51:1335-1339
15. Behre HM, Nieschlag E 1998 Comparative pharmacokinetics of testosterone esters. In: Nieschlag E, Behre HM, eds. Testosterone: action, deficiency, substitution, 2nd Ed. Berlin: Springer; 329-348
16. Ly LP, Jimenez M, Zhuang TN, Celermajer DS, Conway AJ, Handelsman DJ 2001 A double-blind, placebo-controlled, randomized clinical trial of transdermal dihydrotestosterone gel on muscular strength, mobility, and quality of life in older men with partial androgen deficiency. J Clin Endocrinol Metab 86:4078-4088
17. Bailey BJ, Briars GL 1996 Estimating the surface area of the human body. Stat Med 15:1325-1332
18. Ishimaru T, Edmiston WA, Pages L, Horton R 1978 Splanchnic extraction and conversion of testosterone and dihydrotestosterone in man. J Clin Endocrinol Metab 46:528-533
19. Chen W, Thiboutot D, Zouboulis CC 2002 Cutaneous androgen metabolism: basic research and clinical perspectives. J Invest Dermatol 119:992-1007
20. Randall VA, Hibberts NA, Thornton MJ, Hamada K, Merrick AE, Kato S, Jenner TJ, De Oliveira I, Messenger AG 2000 The hair follicle: a paradoxical androgen target organ, MD. Horm Res 54:243-250
21. Gandy HM 1977 Androgens. In: Fuchs F, Klopper A, eds. Endocrinology of pregnancy. Hagerstown, MD: Harper and Row; 123-156
22. Petra P, Stanczyk FZ, Namkung PC, Fritz MA, Novy ML 1985 Direct effect of sex-steroid binding protein (SBP) of plasma on the metabolic clearance rate of testosterone in the rhesus macaque. J Steroid Biochem Mol Biol 22:739-746
23. Elbers JM, Asscheman H, Seidell JC, Gooren LJ 1999 Effects of sex steroid hormones on regional fat depots as assessed by magnetic resonance imaging in transsexuals. Am J Physiol 276:E317-E325
24. Conway AJ, Boylan LM, Howe C, Ross G, Handelsman DJ 1988 A randomised clinical trial of testosterone replacement therapy in hypogonadal men. Int J Androl 11:247-264
25. Handelsman DJ, Conway AJ, Boylan LM 1990 Pharmacokinetics and pharmacodynamics of testosterone pellets in man. J Clin Endocrinol Metab 71: 216-222
26. Jockenhovel F, Vogel E, Kreutzer M, Reinhardt W, Lederbogen S, Reinwein D 1996 Pharmacokinetics and pharmacodynamics of subcutaneous testosterone implants in hypogonadal men. Clin Endocrinol (Oxf) 45:61-71
27. Horst HJ, Holtje WJ, Dennis M, Coert A, Geelen J, Voigt KD 1976 Lymphatic absorption and metabolism of orally administered testosterone undecanoate in man. Klin Wochenschr 54:875-879
28. Tauber U, Schroder K, Dusterberg B, Matthes H 1986 Absolute bioavailability of testosterone after oral administration of testosterone-undecanoate and testosterone. Eur J Drug Metab Pharmacokinet 11:145-149
29. Ciaccio M, Rivarola M, Belgorosky A 1989 Decrease of serum sex hormone-binding globulin as a marker of androgen sensitivity. Correlation with clinical response. Acta Endocrinol (Copenh) 120:540-544
30. Sinnecker G, Kohler S 1989 Sex hormone-binding globulin response to the anabolic steroid stanozolol: evidence for its suitability as a biological androgen sensitivity test. J Clin Endocrinol Metab 68:1195-1200
31. Sinnecker GH, Hiort O, Nitsche EM, Holterhus PM, Kruse K 1997 Functional assessment and clinical classification of androgen sensitivity in patients with mutations of the androgen receptor gene. German Collaborative Intersex Study Group. Eur J Pediatr 156:7-14
32. Comstock GW, Burke AE, Norkus EP, Gordon GB, Hoffman SC, Helzlsouer KJ 2001 Effects of repeated freeze-thaw cycles on concentrations of cholesterol, micronutrients, and hormones in human plasma and serum. Clin Chem 47: 139-142
33. Sinnecker G 1989 Stability of sex-hormone-binding globulin in serum and plasma. Clin Chem 35:1253-1254
34. Williams AE, Maskarinec G, Franke AA, Stanczyk FZ 2002 The temporal reliability of serum estrogens, progesterone, gonadotropins, SHBG and urinary estrogen and progesterone metabolites in premenopausal women. BMC Womens Health 2:13
35. Thigpen AE, Silver RI, Guileyardo JM, Casey ML, McConnell JD, Russell DW 1993 Tissue distribution and ontogeny of steroid 5α-reductase isozyme expression. J Clin Invest 92:903-910
36. Handelsman DJ 2001 Androgen action and pharmacologic uses. In: DeGroot LJ, ed. Endocrinology, 4th Ed. Philadelphia: Saunders; 2232-2242
37. George FW, Russell DW, Wilson JD 1991 Feed-forward control of prostate growth: dihydrotestosterone induces expression of its own biosynthetic enzyme, steroid 5α-reductase. Proc Natl Acad Sci USA 88:8044-8047
38. Cai LQ, Fratiani CM, Gautier T, Imperato-McGinley J 1994 Dihydrotestosterone regulation of semen in males pseudohermaphrodites with 5α-reductase deficiency. J Clin Endocrinol Metab 79:409-414
39. Cai LQ, Zhu YS, Katz MD, Herrera C, Baez J, DeFillo-Ricart M, Shackleton CH, Imperato-McGinley J 1996 5α-Reductase-2 gene mutations in the Dominican Republic. J Clin Endocrinol Metab 81:1730-1735
40. Zaviacic M, Jakubovska V, Belosovic M, Breza J 2000 Ultrastructure of the normal adult human female prostate gland (Skene's gland). Anat Embryol 201:51-61